<?xml version="1.0" encoding="UTF-8"?><marc:collection xmlns:marc="http://www.loc.gov/MARC21/slim">
  <marc:record>
    <marc:leader>00000nam  2200000za 4500</marc:leader>
    <marc:controlfield tag="001">9.822918</marc:controlfield>
    <marc:controlfield tag="003">CaOODSP</marc:controlfield>
    <marc:controlfield tag="005">20221107143801</marc:controlfield>
    <marc:controlfield tag="007">cr |||||||||||</marc:controlfield>
    <marc:controlfield tag="008">160818s2007    onca   |o    f|0| 0 eng d</marc:controlfield>
    <marc:datafield tag="040" ind1=" " ind2=" ">
      <marc:subfield code="a">CaOODSP</marc:subfield>
      <marc:subfield code="b">eng</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="043" ind1=" " ind2=" ">
      <marc:subfield code="a">n-cn---</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="086" ind1="1" ind2=" ">
      <marc:subfield code="a">H14-159/2007E-PDF</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="245" ind1="0" ind2="0">
      <marc:subfield code="a">Bovine Spongiform Encephalopathy I and II formative evaluation </marc:subfield>
      <marc:subfield code="h">[electronic resource] : </marc:subfield>
      <marc:subfield code="b">final report.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="246" ind1="1" ind2="7">
      <marc:subfield code="a">BSE I and II initiatives - formative evaluation - final report</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="260" ind1=" " ind2=" ">
      <marc:subfield code="a">[Ottawa] : </marc:subfield>
      <marc:subfield code="b">Health Canada, </marc:subfield>
      <marc:subfield code="c">2007.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="300" ind1=" " ind2=" ">
      <marc:subfield code="a">xi, 67 p. : </marc:subfield>
      <marc:subfield code="b">ill., figs., tables.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">Issued also in French under title: Encéphalopathie spongiforme bovine (ESB) I et II -- évaluation formative : rapport final.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">"April 27, 2007."</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">"Approved by: Health Canada Departmental Audit and Evaluation Committee."</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="504" ind1=" " ind2=" ">
      <marc:subfield code="a">Includes bibliographic references.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="520" ind1=" " ind2=" ">
      <marc:subfield code="a">The formative evaluation of the Bovine Spongiform Encephalopathy (BSE) I and II Initiatives is a key evaluation for the Health Products and Food Branch (HPFB). An amount of $10.38 million over five years (from April 1, 2003 – March 31, 2008) was allocated to BSE I in order to increase the knowledge and capacity to track and trace a limited number of products that contain bovine-sourced ingredients and thus deal with potential risks to human health. An additional $12.25 million over two years (from April 1, 2004 – March 31, 2006) was allocated to BSE II to enhance the conduct of risk assessments to human health of bovine-derived products and targeted scientific research on BSE and Transmissible Spongiform Encephalopathy (TSE) to increase scientific capacity. There is policy approval for further funding of BSE II activities of up to $21 million over three years (April 1, 2006 – March 31, 2009) for Health Canada and the Public Health Agency of Canada (PHAC) to continue targeted research and risk assessments to address transmission pathways associated with BSE/TSE and human health (see Appendix 1 for a breakdown of funding by directorate and PHAC). ...</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="692" ind1="0" ind2="7">
      <marc:subfield code="2">gccst</marc:subfield>
      <marc:subfield code="a">Health hazards</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="692" ind1="0" ind2="7">
      <marc:subfield code="2">gccst</marc:subfield>
      <marc:subfield code="a">Health protection </marc:subfield>
    </marc:datafield>
    <marc:datafield tag="692" ind1="0" ind2="7">
      <marc:subfield code="2">gccst</marc:subfield>
      <marc:subfield code="a">Program assessment</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="710" ind1="1" ind2=" ">
      <marc:subfield code="a">Canada.</marc:subfield>
      <marc:subfield code="b">Health Canada.</marc:subfield>
      <marc:subfield code="b">Departmental Audit and Evaluation Committee.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="775" ind1="0" ind2="8">
      <marc:subfield code="t">Encéphalopathie spongiforme bovine (ESB) I et II - évaluation formative </marc:subfield>
      <marc:subfield code="w">(CaOODSP)9.822923</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="856" ind1="4" ind2="0">
      <marc:subfield code="q">PDF</marc:subfield>
      <marc:subfield code="s">1.29 MB</marc:subfield>
      <marc:subfield code="u">https://publications.gc.ca/collections/collection_2016/sc-hc/H14-159-2007-eng.pdf</marc:subfield>
    </marc:datafield>
  </marc:record>
</marc:collection>
